Neuropathology of Alzheimer's disease;Neuropathologische aspekte der Alzheimer-Krankheit

Therapeutische Umschau

Volumn 56, Issue 2, 1999, Pages 88-93

  Probst, A ^a   Botez, G ^b   Tolnay, M ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; BRAIN; GENETICS; HUMAN; NERVE CELL; PATHOLOGY; REVIEW; RISK FACTOR;

AGED; ALZHEIMER DISEASE; BRAIN; HUMANS; NEURONS; RISK FACTORS;

EID: 0033070643     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.56.2.88     Document Type: Article

References (18)

1. Alzheimer A.: Über eine eigenartige Erkrankung der Hirnrinde. Zentralblatt für Nervenheilkunde Psychiatrie 18, 177, 1907.
2. Selkoe D.J.: In: The molecular and genetic basis of neurological disease, Rosenberg R.N. et al. Butterworth-Heinemann, Boston, pp. 601-611, 1997.
3. Goedert M., Trojanowski J.Q., Lee V.M.-Y.: In: The molecular and genetic basis of neurological disease, Rosenberg R.N. et al. Butterworth-Heinemann, Boston, pp. 613-622, 1997.
4. Tolnay M., Spillantini M.G., Goedert M., Ulrich J., Langui D., Probst A.: Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol. 93, 477, 1997.
5. Delaere P., He Y., Fayet G., Duyckaerts C., Hauw J.J.: BetaA4 deposits are constant in the brain of oldest old: an immunocytochemical study of 20 french centenarians. Neurobiol. Aging 14, 191, 1993.
6. Probst A., Langui D., Ulrich J.: Alzheimer's disease: A description of the structural lesions. Brain Pathol. 1, 229, 1991.
7. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.-H., Aronson M.K.: Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13, 179, 1991.
8. Probst A., Anderton B., Brion J. P., Ulrich J.: Senile plaque neuntes fail to demonstrate anti-paired helical filament and anti-microtubule-associated protein-tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex. Acta Neuropathol. 77, 430, 1989.
9. Braak H., Braak E.: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239, 1991.
10. Arendt T., Bigl V., Arendt A., Tennstedt A.: Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol. 61, 101, 1983.
11. Roses A.D.: In: The molecular and genetic basis of neurological disease, Rosenberg R.N. et al. Butterworth-Heinemann, Boston, pp. 1019-1035, 1997.
12. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C.P., Perry R., Watson B., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E.: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nature Genet. 19, 357, 1998.
13. Price D.L., Sisodia S.A., Borchelt D.R.: Alzheimer disease - when and why? Nature Genet. 19, 314, 1998.
14. Braak H., Braak E.: Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci. Lett. 76, 124, 1987.
15. Tolnay M., Schwietert M., Monsch A.U., Staehelin H.B., Langui D., Probst A.: Argyrophilic grain disease: distribution of grains in patients with and without dementia. Acta Neuropathol. 94, 353, 1997.
16. Tolnay M., Mistl C., Ipsen S., Probst A.: Argyrophilic grains of Braak: occurrence in dendrites of neurons containing hyperphosphorylated tau protein. Neuropathol. Appl. Neurobiol. 24, 53, 1998.
17. Tolnay M., Probst A., Monsch A.U., Staehelin H.B., Egensperger R.: Apolipoprotein E allele frequencies in argyrophilic grain disease. Acta Neuropathol. 96, 225, 1998.
18. Ghebremedhin E., Schultz C., Botez G., Rüb U., Sassin I., Braak E., Braak H.: Argyrophilic grain disease is associated with apolipoprotein E ε2 allele. Acta Neurophatol. 96, 222, 1998.